Clinical Outcomes and Acute Exacerbation Incidence in Combined Pulmonary Fibrosis and Emphysema
Respirology · 2026-11 · 31 (11) · 1117-1125
DOI: 10.1002/resp.70285 ↗At a glance
Multizentrische Studie in Respirology, published online on 2026-07-08. Written by Kazuya Tsubouchi and 23 co-authors. Institution: Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Major MEDLINE topics: Pulmonary Emphysema, Pulmonary Fibrosis. Cited 1 times so far (Crossref); 30 references. The full text is freely available (open access, CC BY 4.0). Funded by: The Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, Boehringer Ingelheim, The Ministry of Health, Labour and Welfare (MHLW), Japan.
Abstract (original language)
Background and Objective Combined pulmonary fibrosis and emphysema (CPFE) is characterized by coexisting upper‐zone emphysema and lower‐zone fibrosis, but standardized diagnostic criteria and clinical outcomes remain poorly defined. This study aimed to evaluate survival, acute exacerbation incidence, and disease progression in CPFE patients using international classification criteria with visual assessment of emphysema extent.
Methods
This multicentre prospective cohort study at 29 Japanese hospitals enrolled 1016 patients with idiopathic interstitial pneumonias (IIPs) or chronic obstructive pulmonary disease (COPD) between 2013 and 2016. CPFE was defined as ≥ 5% emphysema determined by visual assessment of CT scans for IIP patients, according to international classification criteria. Patients were followed for 5 years.
Results
Among 528 IIP patients, 92 (17.4%) had CPFE. CPFE patients showed a significantly worse 5‐year survival compared with non‐CPFE IIP patients (51.4% vs. 63.1%, p = 0.026) and COPD patients (51.4% vs. 84.0%, p < 0.001). After adjustment for covariates including IIP subtype, CPFE remained independently associated with increased mortality among IIP patients (HR of 1.85 [95% CI, 1.27–2.69], p < 0.001). CPFE patients also had a significantly higher acute exacerbation rate than did non‐CPFE IIP patients ( p < 0.001). The prognostic impact of CPFE was most pronounced in patients with idiopathic pulmonary fibrosis (IPF), with CPFE/IPF patients showing the worst outcomes.
Conclusion
Visual assessment with a ≥ 5% emphysema threshold effectively identified CPFE patients with a distinct clinical phenotype characterized by poor survival and an increased acute exacerbation incidence. These findings validate international classification criteria and emphasize the need for enhanced surveillance and tailored management strategies for this high‐risk population. image
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
- Clinical Research Support Center Kyushu, Fukuoka, Japan.
- Kirigaoka Tsuda Hospital, Kitakyushu, Japan.
- Department of Respiratory Diseases, NHO Fukuokahigashi Medical Center, Koga, Japan.
- Department of Respiratory Medicine, Japan Community Health Care Organization Kurume General Hospital, Kurume, Japan.
- Department of Respiratory Medicine, Fukuoka University Chikushi Hospital, Chikushino, Japan.
ORCID profiles: Kazuya Tsubouchi, Masaki Fujita, Taishi Harada
Funding
- The Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan
- Boehringer Ingelheim
- The Ministry of Health, Labour and Welfare (MHLW), Japan
- Ministry of Health Mexico
Cite
APA
Tsubouchi, K., Kotetsu, Y., Takano, T., Ogata, H., Kiyomi, F., Ichiki, K., Takata, S., Kitasato, Y., Ishii, H., Yatera, K., Yamasaki, K., Okamoto, M., Yoshida, M., Kawasaki, M., Fujita, M., Ogawa, T., Tobino, K., Harada, E., Nakagaki, N., …, & Okamoto, I. (2026). Clinical Outcomes and Acute Exacerbation Incidence in Combined Pulmonary Fibrosis and Emphysema. Respirology, 31(11), 1117-1125. https://doi.org/10.1002/resp.70285
Vancouver
Tsubouchi K, Kotetsu Y, Takano T, Ogata H, Kiyomi F, Ichiki K, et al. Clinical Outcomes and Acute Exacerbation Incidence in Combined Pulmonary Fibrosis and Emphysema. Respirology. 2026;31(11):1117-1125. doi:10.1002/resp.70285
BibTeX
@article{Tsubouchi2026,
author = {Tsubouchi, Kazuya and Kotetsu, Yasuaki and Takano, Tomotsugu and Ogata, Hiroaki and Kiyomi, Fumiaki and Ichiki, Katsuyuki and Takata, Shohei and Kitasato, Yasuhiko and Ishii, Hiroshi and Yatera, Kazuhiro and Yamasaki, Kei and Okamoto, Masaki and Yoshida, Makoto and Kawasaki, Masayuki and Fujita, Masaki and Ogawa, Tomohiro and Tobino, Kazunori and Harada, Eiji and Nakagaki, Noriaki and Komori, Masashi and Harada, Taishi and Wataya, Hiroshi and Nakanishi, Yoichi and Okamoto, Isamu},
title = {Clinical Outcomes and Acute Exacerbation Incidence in Combined Pulmonary Fibrosis and Emphysema},
journal = {Respirology},
year = {2026},
volume = {31},
number = {11},
pages = {1117--1125},
doi = {10.1002/resp.70285}
}
EUVIMED